Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib + Trastuzumab in HER2+ Breast Cancer
NCT00216047Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- Jan 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in breast cancer, sponsored by Hoosier Cancer Research Network. Started Jan 2005; status: terminated.
02
Drugs
vatalanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00216047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216047.